NCT00557531View on ClinicalTrials.gov

Safety and Feasibility of the Injectable BL-1040 Implant

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2014

Conditions
Cardiovascular Disease
Interventions
DEVICE

BL-1040

2 mL of BL-1040

Trial Locations (1)

Unknown

Heidelberg University MC, Heidelberg

Sponsors

Lead Sponsor

BioLineRx, Ltd.
All Listed Sponsors
collaborator

Sheba Medical Center

OTHER_GOV

lead

BioLineRx, Ltd.

INDUSTRY

NCT00557531 - Safety and Feasibility of the Injectable BL-1040 Implant | Biotech Hunter | Biotech Hunter